Evidence map›Paper›PMID 31973767›Full record

ArticleJournal of experimental & clinical cancer research : CR2020

Exosomal circRNA-100338 promotes hepatocellular carcinoma metastasis via enhancing invasiveness and angiogenesis.

Xiu-Yan Huang, Zi-Li Huang, Jin Huang, Bin Xu, Xin-Yu Huang, Yong-Hua Xu, Jian Zhou, Zhao-You Tang

Open access · goldAbstract read
In one paragraph

Article in Journal of experimental & clinical cancer research : CR, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 260 papers.

0numbers the graph read from it
0cells of the map it votes in
260citing papers in PubMed
23.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

260 citing papers in PubMed, 413 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

200 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Xiu-Yan HuangDepartment of General Surgery, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yi Shan Road, Shanghai, 200233, People's Republic of China. xyhuang1119@163.com.
Zi-Li HuangDepartment of Radiology, Xuhui District Central Hospital of Zhongshan Hospital, Fudan University, Shanghai, 200031, People's Republic of China.
Jin HuangDepartment of Pathology, Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai, 200233, People's Republic of China.
Bin XuDepartment of General Surgery, the Tenth People's Hospital of Tongji University, Shanghai, 200072, People's Republic of China.
Xin-Yu HuangDepartment of General Surgery, Shanghai Jiaotong University Affiliated Sixth People's Hospital, 600 Yi Shan Road, Shanghai, 200233, People's Republic of China.
Yong-Hua XuDepartment of Radiology, Xuhui District Central Hospital of Zhongshan Hospital, Fudan University, Shanghai, 200031, People's Republic of China.
Jian ZhouLiver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Zhao-You TangLiver Cancer Institute and Zhongshan Hospital, Fudan University, Shanghai, 200032, People's Republic of China.
Fudan University · CNShanghai Sixth People's Hospital · CNShanghai Tenth People's Hospital · CNZhongshan Hospital · CN

Funding

International Foundation of Translational Medicine for abroad Scholars and Students, U.S. and China UCTMP2015-03C001National Natural Science Foundation of China 81272401the medical-engineering cross fund of Shanghai Jiao Tong University YG2017MS13the pre-research fund of Shanghai sixth People's Hospital LYZY-0229
6 · The paper itself

Abstract

backgroundExosomes play crucial roles in regulating the crosstalk between normal and cancer cells in the tumor microenvironment, and in regulating cancer proliferation, migration and invasion through their cargo molecules.

methodsWe analyzed the pro-invasiveness of exosomal circRNA-100,338 in HCC using the transwell invasion assay. The co-culture of human umbilical vein endothelial cells (HUVEC) and exosomes derived from HCC cell lines were used to evaluate the impact of HCC derived exosomes on HUVEC. Nude mice models were used to validate the findings in vitro. Clinically, quantitative RT-PCR was used to quantify the expression of serum exosomal circRNA-100,338 in HCC patients at both pre-surgery within one week and post-surgery within three weeks.

resultsWe aim to investigate the pro-invasive role of exosomal circRNA-100,338 in HCC metastasis. We for the first time demonstrated that circRNA-100,338 was highly expressed in both highly metastatic HCC cells and their secreted exosomes. The transwell invasion assay showed that the overexpression or knockdown of exosomal circRNA-100,338 significantly enhanced or reduced the invasive abilities of HCC cells. Subsequently, in vitro and in vivo assays showed that exosomal circRNA-100,338 affected the cell proliferation, angiogenesis, permeability, and vasculogenic mimicry (VM) formation ability of human umbilical vein endothelial cells (HUVEC), and tumor metastasis. Furthermore, we also observed that the persistent high expression of exosomal circRNA-100,338 in serum of HCC patients who underwent curative hepatectomy may be a risk indicator of pulmonary metastasis and poor survival.

conclusionsOur findings indicated that metastatic ability of HCC cells could be enhanced by transferring exosomal circRNA-100,338 to recipient HUVECs, which could affect proangiogenic activity by regulating angiogenesis.

Indexed as

AnimalsCarcinoma, HepatocellularDisease Models, AnimalHumansLiver NeoplasmsMaleMiceMice, NudeNeoplasm InvasivenessNeoplasm MetastasisNeovascularization, PathologicRNA, CircularTransfectionRNA, CircularAngiogenesisCircRNA-100,338ExosomeHepatocellular carcinoma (HCC)Tumor metastasis

Identifiers

PMID31973767
PMCPMC6979009
OpenAlexW3000803398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.